EVALUATION OF COPPER, ZINK AND MAGNISIUM IN CERTAIN CHRONIC PROBLEMS

الملخص

and laryngiocarcinoma, as 10 patients for each disease, with 10 normal control. Patients and control were chosen at a nearly same ages in order to reduce the variation in the element ranges. Significant decrease in serum copper concentration ( P < 0. 05 ) occurred for the hypertensive patients ( 110. 3 ± 33 ), and a highly significant increase in serum copper concentration ( P < 0.01 ) was noticed for carcinoma patients ( 172.2 ± 13 ), when each compared with the control copper concentration ( 140 ± 20 ). Moreover, there were non significant increase in copper concentrations of diabetic and chronic renal failure patients ( 160.8 ± 33 ), (154.7± 36) respectively , ( P > 0.05 ), when compared with control copper. Significant increase was noticed in serum zinc concentration of the patients with hypertension (147.1 ± 38 ), ( P < 0.05 ), and a highly significant decrease appear (P<0.01) in serum zinc concentration of carcinoma patients ( 59.6 ± 9 ), when they were compared with control zinc ( 110 ± 6 ). But no significant changes ( P > 0.05 ) occurred for zinc concentrations of diabetic and chronic renal failure patients ( 115. 9 ± 48. 5 ), (101. 5 ± 50) respectively, when each compared with control zinc. No significant changes ( P > 0. 05 ) noticed in serum magnesium concentrations of all patients in the four groups ( hypertension, diabetes mellitus, chronic renal failure and carcinoma ), ( 1. 73 ± 0. 33 ),( 1.76 ± 0.31 ),( 1.98 ± 0. 35 ), ( 1.74 ± 0. 26 ) respectively, when each compared with control magnesium ( 1. 80 ± 0. 12)